Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

Second STOP After Pioglitazone Priming in CML Patients

NCT02889003

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Centre Hospitalier de Versailles Le Chesnay, France
  • Hôpital Bicêtre Le Kremlin-Bicêtre, France
  • CHU Lyon Lyon, France
  • CHU de Nantes Nantes, France
View Trial Details
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT01351545

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Anemia, +43 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Mayo Clinic Arizona (adults) Phoenix, Arizona, United States
View all 142 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

NCT04925479

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Indiana UH Riley H for CIU Indianapolis, Indiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Mississippi Medical Center Jackson, Mississippi, United States
  • Columbia University Medical Center New York Presbyterian New York, United States
View all 39 locations
View Trial Details
Recruiting

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

NCT06802315

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult, Bone Marrow Diseases, +17 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

NCT06887803

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Azienda Ospedaliero Universitaria Careggi Firenze, Struttura Complessa di Ematologia Florence, Italy
  • IRCCS Clinical Institute Humanitas Rozzano, Milan, Italy
  • Istituto di Ematolgia e Oncologia Medica Bologna, Italy
  • Istituto Romagnolo per lo Studio dei Tumori Meldola, Italy
View Trial Details
Recruiting

A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial

NCT06786234

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Hôpital de la Milétrie, CHU Poitiers, New Aquitaine, France
  • CHU Brest Brest, France
  • Institut Paoli-Calmettes Marseille, France
  • CHU Nantes Nantes, France
View all 14 locations
View Trial Details
Recruiting

Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis

NCT07340138

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Kamogawa, Chiba, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
  • Novartis Investigative Site Kamakura, Kanagawa, Japan
  • Novartis Investigative Site Kurashiki, Okayama-ken, Japan
View Trial Details

Related conditions